Niagen Bioscience Inc Share Price

NASDAQ: NAGE

Small Cap

$9.48

-0.20

(-2.07%)

as on September 17, 2025 at 1:29 am IST

$₹

Niagen Bioscience Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$9.42
Day's Price Range
$9.8
$9.48
0.63%
Downside
3.38%
Upside
52 Week's Low
52 Week's High
$5.33
52-Week Price Range
$14.69
$9.48
43.78%
Downside
54.96%
Upside

Niagen Bioscience Inc share price movements today

Previous Close: $9.68
Open: $9.66
Volume: 934.1K
Day's Low - High: $9.42 - $9.8
52 Week Low - High: $5.33 - $14.69

Niagen Bioscience Inc Historical Returns

1 Month Return: -3.39 %
3 Month Return: -31.54 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Niagen Bioscience Inc Stock Fundamentals & Key Indicators

Check Niagen Bioscience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$836.5M

EPS (TTM)

0.1233

Dividend Yield

0.00%

PE Ratio (TTM)

Industry PE ratio

P/B Ratio

PEG Ratio

Return On Equity TTM

33.47%

Niagen Bioscience Inc Stock Valuation

Track how Niagen Bioscience Inc P/E has moved over time to understand its valuation trends.

Niagen Bioscience Inc in the last 5 years

Overview
Trends

Lowest (77.34x)

March 31, 2025

Industry (0.00x)

September 16, 2025

Today (59.00x)

September 16, 2025

Highest (77.34x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 59.00x

Niagen Bioscience Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Niagen Bioscience Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Niagen Bioscience Inc	NA	$836.5M	NA	59	13.07%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Niagen Bioscience Inc Stock's Interest Amongst Investors

Search interest for Niagen Bioscience Inc Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-24% versus previous 30 day period

Niagen Bioscience Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	22	20	19	21	22	22	25	29	30	31
Gross Profit	13	12	11	12	13	13	16	18	19	20
Operating Income	-1	-2	-1	0	0	0	1	7	4	3
EBITDA	-1	-1	0	0	0	0	1	7	5	3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	0	0	0	0	0	0	0
Income Before Tax	-1	-2	0	0	0	0	1	7	5	3
Income Tax Expense	-	-	-	-	-	-	-	0	0	0
Net Income	-1	-2	0	0	0	0	1	7	5	3
Net Profit Margin	-8.43%	-10.78%	-4.92%	0.54%	-2.22%	-0.07%	7.34%	24.65%	16.61%	11.60%

Niagen Bioscience Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	17	21	21	31	46	59	67	72	83	99
Gross Profit	7	10	10	16	25	35	41	42	50	61
Operating Income	-2	-2	-16	-33	-31	-19	-27	-18	-5	7
EBITDA	-1	-2	-15	-32	-29	-18	-25	-16	-3	9
Interest Expense	0	0	-	-	0	0	0	-	-	-
Depreciation	-	-	-	-	-	-	1	1	1	1
Income Before Tax	-2	-3	-16	-33	-32	-19	-27	-16	-4	8
Income Tax Expense	0	-	-	-	-	-	-	-	-	0
Net Income	-2	-2	-11	-33	-32	-19	-27	-16	-4	8
Net Profit Margin	-15.49%	-13.52%	-53.67%	-105.57%	-69.45%	-33.62%	-40.22%	-22.96%	-5.91%	8.58%

Niagen Bioscience Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	1	7	5	3
Operating Cash Flow	3	3	8	7	1
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	0	1	3	3	3
Change in Cash	3	4	12	10	4

Niagen Bioscience Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-11	-33	-32	-19	-27	-16	-4	8
Operating Cash Flow	-2	-9	-20	-20	-10	-24	-15	7	12
Investing Cash Flow	-1	4	-1	0	0	0	0	0	0
Financing Cash Flow	0	48	0	16	8	36	7	0	5
Change in Cash	-3	43	-22	-3	-2	11	-7	6	17

Insights on Niagen Bioscience Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 8 quarters, 19.49M → 31.11M (in $), with an average increase of 6.4% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NAGE has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NAGE has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 3 months, NAGE stock has moved down by -31.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 7.17M → 3.60M (in $), with an average decrease of 29.1% per quarter

About Niagen Bioscience Inc

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Organisation	Niagen Bioscience Inc
Headquarters	10900 Wilshire Blvd, Los Angeles, CA, United States, 90024
CEO	Mr. Robert N. Fried
E-voting on shares	Click here to vote

Key Management of Niagen Bioscience Inc

Name	Title
Ms. Michiko Kelley	Chief Marketing Officer
Ms. Chu Yan	Managing Director of Asia Pacific
Mr. Frank Louis Jaksch Jr.	Co-Founder & Chairman
Mr. Ozan Pamir C.F.A.	CFO & Principal Accounting Officer
Mr. Carlos Lopez	Senior VP & General Counsel
Mr. James Lee	Controller
Mr. Robert N. Fried	CEO & Director
Dr. Andrew Shao Ph.D.	Senior Vice President of Global Regulatory & Scientific Affairs
Kendall Knysch	Head of Media Relations & Partnerships
Wesley Yu	Vice President of Finance

FAQs

What is Niagen Bioscience Inc share price today?

Niagen Bioscience Inc share price today is $9.48 as on September 17, 2025 at 1:29 am IST at the close of the market. Niagen Bioscience Inc share today touched a day high of $9.8 and a low of $9.42.

What is the 52 week high and 52 week low for Niagen Bioscience Inc share?

Niagen Bioscience Inc share touched a 52 week high of $14.69 on June 30, 2025 and a 52 week low of $5.33 on April 9, 2025. Niagen Bioscience Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $9.48,which is 35.47% down from its 52 week high and 77.86% up from its 52 week low.

What is Niagen Bioscience Inc's market capitalisation today?

Niagen Bioscience Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Niagen Bioscience Inc Stock (NAGE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Niagen Bioscience Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Niagen Bioscience Inc Shares that will get you 0.1582 shares as per Niagen Bioscience Inc share price of $9.48 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Niagen Bioscience Inc Stock (NAGE) from India?

Indian investors can start investing in Niagen Bioscience Inc (NAGE) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Niagen Bioscience Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 4:37 am IST). Based on Niagen Bioscience Inc share’s latest price of $9.48 as on September 17, 2025 at 1:29 am IST, you will get 1.0549 shares of Niagen Bioscience Inc. Learn more about fractional shares .